Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
about
Infection with MERS-CoV causes lethal pneumonia in the common marmosetAdaptive evolution of bat dipeptidyl peptidase 4 (dpp4): implications for the origin and emergence of Middle East respiratory syndrome coronavirusMiddle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak controlReceptor-binding domain-based subunit vaccines against MERS-CoVCurrent advancements and potential strategies in the development of MERS-CoV vaccinesCrystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome CoronavirusStructure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitorAnimal models of Middle East respiratory syndrome coronavirus infectionA decade after SARS: strategies for controlling emerging coronavirusesSearching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirusMolecular aspects of MERS-CoV.MERS-CoV spike protein: a key target for antivirals.Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines.A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variantExceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.Bat origin of human coronaviruses.Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike proteinCryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domainsIdentification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.Full-genome sequence of human betacoronavirus 2c jordan-n3/2012 after serial passage in Mammalian cells.Domestic Pig Unlikely Reservoir for MERS-CoV.A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.Structure, Function, and Evolution of Coronavirus Spike Proteins.The emergence of the Middle East respiratory syndrome coronavirusHost species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4.Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus.Computer aided prediction and identification of potential epitopes in the receptor binding domain (RBD) of spike (S) glycoprotein of MERS-CoV.Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseThe amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents.A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccinesReceptor recognition mechanisms of coronaviruses: a decade of structural studies.Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.Laboratory investigation and phylogenetic analysis of an imported Middle East respiratory syndrome coronavirus case in GreeceMERS-CoV in Upper Respiratory Tract and Lungs of Dromedary Camels, Saudi Arabia, 2013-2014Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
P2860
Q21131359-BF83B39C-A09B-4C12-85F0-66406C0051E0Q21231948-33129C04-A072-41DD-9082-C79F664779C4Q26796501-A3814217-C733-4A64-9CF9-C84BCB7CE152Q26851979-31175852-3840-43E2-9B7D-119E11084260Q27012578-72F9D7A5-1C58-4B70-BBA4-3D3037550A20Q27679307-27963460-4941-4EF7-9921-30B546544D1CQ27689029-99C26410-F85E-49B6-A301-09BDA134A357Q28086778-46044769-A980-4028-83AB-E396C605FE12Q28817689-A68E38EB-BEB6-47B4-BBEE-BF70FD9ED154Q28873816-9425B5A9-A9D4-4062-907C-EDABDC1E1F65Q30234479-1C42C1B9-D2E7-4D23-8AB6-B50FE47205AAQ30240139-CFF3A264-DDEC-4A50-8D73-30C1BF883568Q30359335-9CCF8343-2308-4D8C-934C-851D112BD71CQ30360627-B1274ACF-479D-4D78-AE0C-01E7D2B13249Q30362113-CDDDACC0-85CF-43E4-A76A-752B6C63FDBBQ30371303-78CD24F7-395F-4C90-9C32-EAF7249E578FQ30379384-685AE09B-2637-4129-8E11-9E212F213D0BQ30382230-C141C27A-5B50-44D5-9B01-EDEC60E5E017Q30382750-3269F621-25AF-4311-AC77-7ED04D59E1D2Q30399700-D8B314A8-6F86-472F-BF99-B7B23FD740DBQ30402347-6918A347-CBC5-4F9A-B88B-3974CFABFD97Q30845557-4A5590A7-B180-4E6E-872A-1B2A0FF66437Q33627189-FFEAF680-4E13-4371-872C-3FC0AC26D891Q33687339-448B8138-6625-4267-80BE-41D5D54C3671Q33724639-C7A29C34-4989-4A9A-8F88-210E9365234FQ33743790-86EA2397-92D4-46FC-BD8A-3C75E665883FQ33760875-CF465531-D572-4DE5-A7B7-9D90DDBE1203Q33934034-55ED7C5C-0B9C-44BF-8A1F-37CABAD45A21Q34059153-8E6294C6-552B-4173-AB80-4B0E04F015D8Q34120263-7B2DB780-EEA7-4176-9960-FBC5168899D8Q34201227-364FEF73-EE0C-46C9-9E46-4BEEAB031AD6Q34324907-AA6EA3DB-095E-4D7C-94F9-472F666E738CQ34468689-6196D2EB-C6C3-48A8-AA43-FCBC509CCFC9Q34652511-2E2A8EB6-5B0E-4386-B94F-4A57FA377E16Q35063993-85EDDD05-07E8-457F-8172-BD7B1D55AD65Q35115572-7B290FA1-E08C-4E80-800F-B4DA7F4B8288Q35159147-954CE83F-5C2B-4983-A560-5AE7E62D5639Q35546907-1B31BBF0-C3BE-4D27-AD0E-BFDFA8A45BA3Q35780285-2F77B3D5-89B0-47C9-BB0D-967038694596Q35865538-4ACE5EC2-8642-476C-9623-49240F8FA2F8
P2860
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
@ast
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
@en
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
@nl
type
label
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
@ast
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
@en
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
@nl
prefLabel
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
@ast
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
@en
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
@nl
P2093
P2860
P3181
P356
P1433
P1476
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
@en
P2093
Dongli Wang
Dongxing Guo
Kelly C Arledge
Linqi Zhang
Liwei Jiang
Nianshuang Wang
Senyan Zhang
P2860
P2888
P304
P3181
P356
10.1038/CR.2013.92
P577
2013-08-01T00:00:00Z
P5875
P6179
1038542882